2023
DOI: 10.1039/d3nr01482g
|View full text |Cite
|
Sign up to set email alerts
|

RNA-cleaving DNAzymes for accurate biosensing and gene therapy

Abstract: RNA-cleaving DNAzymes, which are single-stranded catalytic DNA, have attracted considerable attention in bioanalysis and biomedical applications because of their high stability, high catalytic activity, easy synthesis, easy functionalization, and modification....

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 196 publications
(223 reference statements)
0
2
0
Order By: Relevance
“…[7] DNAzymes exhibit higher chemical and thermal stability than their RNA counterparts enabling their use in biological systems. [8] In vivo sensing applications of DNAzymes typically suffer from false positive signaling, because the co-factors are present in the biological environment, so the DNAzyme activates before reaching its target site. To overcome this problem, a number of caging-decaging strategies have been developed to enable spatiotemporal control over DNAzyme activity.…”
Section: Introductionmentioning
confidence: 99%
“…[7] DNAzymes exhibit higher chemical and thermal stability than their RNA counterparts enabling their use in biological systems. [8] In vivo sensing applications of DNAzymes typically suffer from false positive signaling, because the co-factors are present in the biological environment, so the DNAzyme activates before reaching its target site. To overcome this problem, a number of caging-decaging strategies have been developed to enable spatiotemporal control over DNAzyme activity.…”
Section: Introductionmentioning
confidence: 99%
“…15,16 Due to these excellent properties, DNAzyme has already been applied to gene therapy for various diseases caused by mutations in genes such as cancer, cardiovascular disease, and viral infection. 14 Among various DNAzymes, 8−17 DNAzyme and 10−23 DNAzyme are mainly used as gene-silencing agents, which catalyze the cleavage of RNA, but 8−17 DNAzyme, which is easy to make reasonable design modifications, is considered to have a higher potential. 17,18 However, despite the many advantages of DNAzyme, they exhibit low efficacy in vivo and in cells due to issues such as insufficient stability against nuclease and low intracellular delivery efficiency.…”
Section: Introductionmentioning
confidence: 99%
“…Among these, DNAzymes, unlike other agents based on protein enzymes, consist only of DNA strands and are composed of a catalytic domain that exhibits catalytic activity by binding with a cofactor metal cation and binding domains that can bind to substrate RNA. Due to these characteristics of DNAzyme, it has the advantage of having high specificity and flexibility compared to other agents. , In particular, DNAzyme has higher physiological stability than siRNA and has higher gene-silencing efficiency than ASO, which relies on the activity of endogenous RNase H . In addition, DNAzymes have advantages such as low immunogenicity, low cost, and easy functionalization. , Due to these excellent properties, DNAzyme has already been applied to gene therapy for various diseases caused by mutations in genes such as cancer, cardiovascular disease, and viral infection …”
Section: Introductionmentioning
confidence: 99%
“…This process effectively downregulates VEGF expression and triggers apoptosis in tumor cells. 17 The nanoprobe not only enables selective fluorescence imaging of survivin mRNA in live cells but also accurately distinguishes tumor cells from normal cells. Additionally, it selectively induces apoptosis in tumor cells.…”
Section: Introductionmentioning
confidence: 99%